Adjuvant Recombinant SARS-CoV-2 Spike Protein Vaccine Immunogenicity After Prior mRNA Vaccine Doses

Jeffrey M. Adelglass, Paul Bradley, Miranda R. Cai, Gordon Chau, Raj Kalkeri, Shane Cloney-Clark, Mingzhu Zhu, Zhaohui Cai, Mark Eickhoff, Joyce S. Plested, Raburn M. Mallory, Lisa M. Dunkle
doi: https://doi.org/10.1101/2024.11.07.24316865

Data Availability

Study information is available online at links provided. Requests submitted to the corresponding author will be considered.

https://www.clinicaltrials.gov/study/NCT05875701?term=2019nCoV-312&rank=1

https://www.clinicaltrials.gov/study/NCT05463068?term=NCT05463068&rank=1

Back to top
Posted November 08, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Adjuvant Recombinant SARS-CoV-2 Spike Protein Vaccine Immunogenicity After Prior mRNA Vaccine Doses
Jeffrey M. Adelglass, Paul Bradley, Miranda R. Cai, Gordon Chau, Raj Kalkeri, Shane Cloney-Clark, Mingzhu Zhu, Zhaohui Cai, Mark Eickhoff, Joyce S. Plested, Raburn M. Mallory, Lisa M. Dunkle
medRxiv 2024.11.07.24316865; doi: https://doi.org/10.1101/2024.11.07.24316865
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area